- Home
- MRVI vs HYLN Comparison
MRVI vs HYLN Comparison
Compare MRVI & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- HYLN
- Stock Information
- Founded
- MRVI 2014
- HYLN 2018
- Country
- MRVI United States
- HYLN United States
- Employees
- MRVI N/A
- HYLN N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- HYLN Construction/Ag Equipment/Trucks
- Sector
- MRVI Health Care
- HYLN Consumer Discretionary
- Exchange
- MRVI Nasdaq
- HYLN Nasdaq
- Market Cap
- MRVI 376.2M
- HYLN 347.4M
- IPO Year
- MRVI 2020
- HYLN N/A
- Fundamental
- Price
- MRVI $3.34
- HYLN $2.33
- Analyst Decision
- MRVI Hold
- HYLN
- Analyst Count
- MRVI 9
- HYLN 0
- Target Price
- MRVI $4.54
- HYLN N/A
- AVG Volume (30 Days)
- MRVI 1.4M
- HYLN 1.6M
- Earning Date
- MRVI 11-06-2025
- HYLN 11-13-2025
- Dividend Yield
- MRVI N/A
- HYLN N/A
- EPS Growth
- MRVI N/A
- HYLN N/A
- EPS
- MRVI N/A
- HYLN N/A
- Revenue
- MRVI $219,830,000.00
- HYLN $3,513,000.00
- Revenue This Year
- MRVI N/A
- HYLN $288.93
- Revenue Next Year
- MRVI $7.23
- HYLN $312.76
- P/E Ratio
- MRVI N/A
- HYLN N/A
- Revenue Growth
- MRVI N/A
- HYLN 3559.38
- 52 Week Low
- MRVI $1.67
- HYLN $1.11
- 52 Week High
- MRVI $8.54
- HYLN $4.10
- Technical
- Relative Strength Index (RSI)
- MRVI 69.44
- HYLN 67.85
- Support Level
- MRVI $2.94
- HYLN $1.90
- Resistance Level
- MRVI $3.30
- HYLN $2.15
- Average True Range (ATR)
- MRVI 0.20
- HYLN 0.17
- MACD
- MRVI 0.04
- HYLN 0.01
- Stochastic Oscillator
- MRVI 91.98
- HYLN 75.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About HYLN Hyliion Holdings Corp.
Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.